BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20447959)

  • 1. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.
    Roufas A; Jalaludin B; Gaskin C; McCluskey P
    Br J Ophthalmol; 2010 Jun; 94(6):743-7. PubMed ID: 20447959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis.
    Albini TA; Zamir E; Read RW; Smith RE; See RF; Rao NA
    Ophthalmology; 2005 Oct; 112(10):1814-20. PubMed ID: 16199269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.
    Sohn EH; Wang R; Read R; Roufas A; Teo L; Moorthy R; Albini T; Vasconcelos-Santos DV; Dustin LD; Zamir E; Chee SP; McCluskey P; Smith R; Rao N
    Ophthalmology; 2011 Oct; 118(10):1932-7. PubMed ID: 21708408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.
    Zamir E; Read RW; Smith RE; Wang RC; Rao NA
    Ophthalmology; 2002 Apr; 109(4):798-805; discussion 805-7. PubMed ID: 11927443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sub-Tenon triamcinolone acetonide injections in the treatment of scleritis.
    Johnson KS; Chu DS
    Am J Ophthalmol; 2010 Jan; 149(1):77-81. PubMed ID: 19875093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection.
    Tu EY; Culbertson WW; Pflugfelder SC; Huang A; Chodosh JC
    Ophthalmology; 1995 May; 102(5):718-24. PubMed ID: 7777270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular scleritis following alendronate therapy.
    Tabbara KF
    Ocul Immunol Inflamm; 2008; 16(3):99-101. PubMed ID: 18569796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis.
    Sen HN; Ursea R; Nussenblatt RB; Buggage RR
    Br J Ophthalmol; 2005 Jul; 89(7):917-8. PubMed ID: 15965178
    [No Abstract]   [Full Text] [Related]  

  • 9. Scleritis therapy.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
    Konstantopoulos A; Williams CP; Luff AJ
    Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep intramuscular methylprednisolone treatment of recurrent scleritis.
    Deokule S; Saeed T; Murray PI
    Ocul Immunol Inflamm; 2005 Feb; 13(1):67-71. PubMed ID: 15804772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival triamcinolone acetonide injection in the treatment of acute noninfectious nonnecrotizing anterior scleritis.
    Onal S; Asfuroglu E; Kazokoglu H
    Am J Ophthalmol; 2010 Jun; 149(6):1012; author reply 1012-3. PubMed ID: 20510689
    [No Abstract]   [Full Text] [Related]  

  • 13. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
    Athanasiadis Y; Tsatsos M; Sharma A; Hossain P
    J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series.
    Chee E; Chee SP
    Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Subconjunctival Triamcinolone Acetate-associated Scleral Necrosis: Is It Really Obsolete?
    Agarwal R; Bafna RK; Chetan C; Sharma N
    Optom Vis Sci; 2021 Sep; 98(9):1016-1020. PubMed ID: 34433205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M; Vu L; Whitson JT; He YG
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.